• Produktbild: Cardiac Positron Emission Tomography
  • Produktbild: Cardiac Positron Emission Tomography
Band 165

Cardiac Positron Emission Tomography

Fr. 359.00

inkl. gesetzl. MwSt., Versandkostenfrei


Beschreibung

Produktdetails

Einband

Taschenbuch

Erscheinungsdatum

27.09.2011

Herausgeber

Markus Schwaiger

Verlag

Springer Us

Seitenzahl

366

Maße (L/B/H)

23.5/15.5/2.2 cm

Gewicht

610 g

Auflage

Softcover reprint of the original 1st ed. 1996

Sprache

Englisch

ISBN

978-1-4612-8524-3

Beschreibung

Rezension

`
... this book is highly recommendable for everybody involved in CPET. It is also a readable source of information not only to nuclear medicine physicists but also to cardiologists, cardiac surgeons, physiologists and clinical physicists and radiopharmacists. This book should gain widespread acceptance... The scientific accuracy is undoubtedly high; the quality of written contributions is perfect, as is the quality of all presented figures; there is also a chapter on color display.
'

European Journal of Nuclear Medicine, 24:2 (1997)

Produktdetails

Einband

Taschenbuch

Erscheinungsdatum

27.09.2011

Herausgeber

Markus Schwaiger

Verlag

Springer Us

Seitenzahl

366

Maße (L/B/H)

23.5/15.5/2.2 cm

Gewicht

610 g

Auflage

Softcover reprint of the original 1st ed. 1996

Sprache

Englisch

ISBN

978-1-4612-8524-3

Herstelleradresse

Springer-Verlag KG
Sachsenplatz 4-6
1201 Wien
AT

Email: GPSR Kontakt

Noch keine Bewertungen vorhanden

Verfassen Sie die erste Bewertung zu diesem Artikel

Helfen Sie anderen Kundinnen und Kunden durch Ihre Meinung.

Kundinnen und Kunden meinen

Bewertungen (0)

  • Produktbild: Cardiac Positron Emission Tomography
  • Produktbild: Cardiac Positron Emission Tomography
  • Introduction; M. Schwaiger. Methodology:- 1. Trends in instrumentation; J.T. Spinks, J. Jones. 2. Attenuation correction: Practical considerations; S.L. Bacharach. 3. Radiopharmaceuticals; M.R. Kilbourn. 4. Utility and limitations of (18F)2-deoxy-2-fluoro-D-glucose for the assessment of flux through metabolic pathways in heart muscle: A critical appraisal; H. Taegtmeyer. 5. Quantitative evaluation of myocardial perfusion; G.D. Hutchins, M. Schwaiger. Myocardial Perfusion Imaging:- 6. Assessment of myocardial perfusion with 13N-Ammonia or 82-Rubidium; M. Schwaiger, et al. 7. Assessment of myocardial perfusion with 15-O Water; P. Herrero, S.R. Bergmann. 8. 62Cu-PTSM: A generator-based radiopharmaceutical for myocardial perfusion imaging; M.A. Green. 9. Comparison of cost-effectiveness of myocardial perfusion imaging versus other approaches: Predictions by a model; R.E. Patterson, et al. Assessment of Tissue Viability:- 10. Assessment of blood flow and substrate metabolism in the myocardium of the normal human heart; H.R. Schelbert. 11. Comparison of SPECT and PET for assessment of tissue viability; R. Bonow. 12. 11C-Acetate in ischemic heart disease; R.J. Gropler. 13. Assessment of myocardial viability using 15O-Water; H. Iida, et al. 14. Myocardial 82Rubidium kinetics identify cell membrane integrity and tissue viability; J. vom Dahl, M. Schwaiger. 15. Imaging hypoxic myocardium; G.V. Martin, et al. Other Applications:- 16. Quantification of myocardial oxygen consumption using 11C-Acetate; R. Beanlands, et al. 17. Applications in non-ischemic heart disease and heart failure; R. Beanlands, H.G. Wolpers. 18. The use of PET radiopharmaceuticals to probe cardiac receptors; H. Valette, et al. Appendix:- 19. Clinical PET protocols; J.M. Rothley, A.R.J. Weeden. Index.